A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma

NANot yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2028

Conditions
Extranodal Natural Killer/T-cell Lymphoma
Interventions
DIAGNOSTIC_TEST

circulate free methylated EBV DNA

Accuracy of circulating free methylated EBV DNA in predicting 2-year PFS

Trial Locations (1)

Unknown

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
collaborator

Zhenjiang First People's Hospital

OTHER

collaborator

Changzhou First People's Hospital

UNKNOWN

collaborator

Changzhou Second People's Hospital

UNKNOWN

collaborator

Wuxi People's Hospital

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

The First Affiliated Hospital of Nantong University

UNKNOWN

collaborator

Huaian first people's hospital

UNKNOWN

collaborator

Yancheng First People's Hospital

OTHER

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER